No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran - Sarich,T.C.; Teng,R.; Peters,G.R. (Clin Pharmacokinet, 2003)